NRX Pharmaceuticals: D. Boral Capital Raises Buy Rating, PT to $34 from $34.

miércoles, 3 de diciembre de 2025, 3:31 pm ET1 min de lectura
NRXP--

NRX Pharmaceuticals: D. Boral Capital Raises Buy Rating, PT to $34 from $34.

NRX Pharmaceuticals: D. Boral Capital Raises Buy Rating, PT to $34 from $34.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios